Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New developments in chemotherapy reported at DDW

May 30, 1997

Eisai develops agents for brain cancer

May 30, 1997

Oxigene signs agreement for combretastatin development

May 29, 1997

Vital to develop anticancer drug

May 29, 1997

Activated Cell Therapy's immunotherapy for prostate cancer enters clinic

May 29, 1997

Hayashibara discloses potent, broad-spectrum antitumor agents

May 29, 1997

Prodrugs of nitrogen mustard with selective antitumor activity

May 27, 1997

Natural antitumor compounds described by Banyu

May 27, 1997

Inhibitors of 5alpha-reductase from Kyowa Hakko

May 27, 1997

Banyu discovers potent new antitumor agent

May 27, 1997

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...